Clinical immunology (Orlando, Fla.) · 2009
Lymphocyte characteristics in children with common variable immunodeficiency.
Сравнительное исследованиеСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
van de Ven Annick A J M, van de Corput Lisette, van Tilburg Cornelis M, Tesselaar Kiki, van Gent Rogier, Sanders Elisabeth A M, Boes Marianne, Bloem Andries C, van Montfrans Joris M
Аннотация
The diagnosis of common variable immunodeficiency (CVID) is reserved for patients who suffer from undefined B cell dysfunction. Division of the CVID population into subgroups enables research for underlying disease causes. We studied clinical features and lymphocyte characteristics in 38 children with CVID and compared them to 30 children with less severe antibody deficiencies (e.g. specific antibody deficiency combined with IgG subclass deficiency) and with 65 pediatric controls. Most pediatric immune phenotypes were comparable to adult CVID phenotypes, including a selective increase in newly formed B cells and a decrease in memory B cells and CD4(+) T cells. Eighteen percent of pediatric patients had a mutation in the TNFRSF13B gene, which requires further investigation. Finally, pediatric patients with decreased class-switched memory B cells had significantly more complications. A pediatric classification for CVID may enable prediction and early diagnosis of disease related complications and provide a framework for further etiologic research.
Предметные рубрики MeSH
B-LymphocytesCell DifferentiationChildChild, PreschoolCohort StudiesCommon Variable ImmunodeficiencyDNAFemaleFlow CytometryGenetic VariationHumansMalePolymerase Chain ReactionRetrospective StudiesSequence Analysis, DNAStatistics, NonparametricT-LymphocytesTransmembrane Activator and CAML Interactor Protein